Cormorant Global Healthcare GP, LLC is Director & 10% Owner at PROTEOSTASIS THERAPEUTICS, INC. (PTI). They have made 6 open-market trades across 2 companies since 2016, most recently 2018-10-31.
CIK 0001618451
6 open-market purchases totalling $16.8M since 2016, never a sale. Across 6 scored buys the stock is up 18.4% at ninety days, and 13.1 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 67% | 83% | 83% |
| Avg Move | +4.4% | +15.0% | +18.4% |
| Alpha | +3.7% | +13.4% | +13.1% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AXNX | BUY | 2018-10-31 | 2018-11-02 | $15.00 | $2.0M | -0.1% | -7.5% | -3.6% |
| PTI | SELL · Routine | 2017-12-14 | 2017-12-18 | $4.88 | $2.5M | +23.5% | -9.3% | +48.1% |
| PTI | BUY | 2016-12-12 | 2016-12-14 | $10.85 | $1.5M | +17.1% | +21.1% | +18.0% |
| PTI | BUY | 2016-12-07 | 2016-12-09 | $10.83 | $962K | +9.8% | +24.7% | +7.8% |
| PTI | BUY | 2016-12-02 | 2016-12-06 | $10.68 | $1.3M | +2.7% | +26.3% | +20.7% |
| PTI | BUY | 2016-11-29 | 2016-12-01 | $10.24 | $3.5M | +4.7% | +20.9% | +40.7% |
| PTI | BUY | 2016-11-21 | 2016-11-23 | $11.43 | $7.5M | -7.7% | +4.7% | +26.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.